Management of renal anaemia: comparison of practice in the Czech Republic and Northern England

EDTNA ERCA J. 2004 Apr-Jun;30(2):75-83. doi: 10.1111/j.1755-6686.2004.tb00340.x.

Abstract

The EDTNA/ERCA European Practice Database (EPD) questionnaire was piloted in the Czech Republic (CZ), Northern Italy and Northern England (N-ENG) in early 2003. The questionnaire used in the CZ and N-ENG featured additional questions on the use of erythropoetin (EPO) and intravenous (IV) iron. There were significant differences in the policies for anaemia management in the CZ and N-ENG, reflecting the higher level of funding available to centres in the UK. There was also a wide variation in practice between the CZ centres, but not those in N-ENG, possibly due to the adoption of guidelines that are currently unrealistic. Some centres, particularly those in the CZ, could improve outcomes or reduce overall costs by adopting a more aggressive policy for the use of intravenous iron.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia / blood
  • Anemia / drug therapy*
  • Anemia / etiology
  • Czech Republic
  • England
  • Erythropoietin / therapeutic use*
  • Humans
  • Iron / therapeutic use*
  • Kidney Failure, Chronic / complications*
  • Practice Guidelines as Topic
  • Recombinant Proteins / therapeutic use*

Substances

  • Recombinant Proteins
  • Erythropoietin
  • Iron